Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Aabha Oza"'
Autor:
Patrick Soon-Shiong, Aabha Oza, Julie Ritchey, Michael P. Rettig, Leah Gehrs, David B. Clifford, Amy Rock, Christopher A. Miller, Phil Powell, John F. DiPersio, Todd A. Fehniger, Julia Hollaway, Kathryn O’Brien, Eugene O. Major
Publikováno v:
Blood Adv
Key PointsTherapy with an IL-15 superagonist resulted in immune and clinical responses in a transplant recipient with PML.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5203698a785a946bf574534a7061b7f
https://europepmc.org/articles/PMC7284083/
https://europepmc.org/articles/PMC7284083/
Autor:
Cynthia X. Ma, Aabha Oza
Publikováno v:
Current Breast Cancer Reports. 9:13-25
Estrogen receptor-positive (ER+) breast cancer represents the majority of breast cancer diagnoses and is the leading cause of cancer death in women. Endocrine therapy is the principal treatment strategy for ER+ breast cancer. However, resistance to e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3822a8f35b5210afe498ff650797ad6e
https://doi.org/10.1007/s12609-017-0231-1
https://doi.org/10.1007/s12609-017-0231-1
Autor:
Andrea Wang-Gillam, Kathryn J. Fowler, William G. Hawkins, Benjamin R. Tan, Chet W. Hammill, Kian-Huat Lim, Manik Amin, Patrick M. Grierson, Ashley Morton, Aabha Oza, M.B. Majella Doyle, Christine Cordova, Katrina S. Pedersen, William C. Chapman, Ryan C. Fields
BACKGROUND: The standard of care for unresectable intrahepatic cholangiocarcinoma (ICC) is palliative systemic chemotherapy with cisplatin and gemcitabine. The use of hepatic arterial infusion (HAI) floxuridine (FUDR) with systemic chemotherapy may i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24880c7e62a4c77ad28bfb044e27d5cd
https://europepmc.org/articles/PMC6421181/
https://europepmc.org/articles/PMC6421181/
Publikováno v:
Journal of Clinical Oncology. 36:e16542-e16542
e16542Background: Germ cell tumor (GCT) is the most common cancer effecting males aged 15 to 35. With the implementation of cisplatin-based chemotherapy and/or surgery, the cure rate in early-stage...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62e818e2eea5ff1e5b4b2d779abc9eb9
https://doi.org/10.1200/jco.2018.36.15_suppl.e16542
https://doi.org/10.1200/jco.2018.36.15_suppl.e16542
Publikováno v:
Chest. 137:1145-1149
It is uncertain whether pathologically prolonged international normalized ratio (INR) seen in chronic liver disease (CLD) protects against venous thromboembolism (VTE). Previous studies reported VTE incidence of 0.5% to 1.9% in patients with CLD. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62adf742c9424bc664dc55ff26fc7d49
https://doi.org/10.1378/chest.09-2177
https://doi.org/10.1378/chest.09-2177
Autor:
James W. Fleshman, Katrina Pedersen, Andrea Wang-Gillam, Thomas C. Westbrook, Sean C. Glasgow, Rama Suresh, Samantha Marquez, Ashley Morton, Matthew G. Mutch, Stephen Barman, Aabha Oza, Benjamin R. Tan, Patrick M. Grierson
Publikováno v:
Journal of Clinical Oncology. 36:746-746
746 Background: Peritoneal carcinomatosis (PC) is the intraperitoneal spread of cancer. Optimal treatment for PC is controversial. Systemic chemotherapy offers limited benefit (Franko, 2011). Intraperitoneal (IP) chemotherapy following cytoreductive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::49d51641f228685ade41f3d914315657
https://doi.org/10.1200/jco.2018.36.4_suppl.746
https://doi.org/10.1200/jco.2018.36.4_suppl.746